Riskpilot← Back to searchSign inGet full accessDATEC MEDICO ApS
APSActiveCVR 32828183Ved Skoven 35, 1.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201011 employeeswww.datecmedico.dk
Revenue 2024
DKK 1,8M
-1% vs 2023
EBITDA margin
-182.2%
-89% vs 2023
Equity ratio
-8.5%
Financial strength
Net profit 2024
DKK -3,1M
-43% vs 2023
| Revenue | DKK 1,8M | -1% |
| EBITDA | DKK -3,2M | -89% |
| Net profit | DKK -3,1M | -43% |
| Total assets | DKK 31,2M | +166% |
| Equity | DKK -2,7M | -715% |
| Employees | 11 | — |
Legal name
DATEC MEDICO ApS
CVR number
32828183
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23. marts 2010
Share capital
DKK 200.000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør sammen med bestyrelsesformanden, bestyrelsesformanden sammen med et andet bestyrelsesmedlem eller af den samlede bestyrelse i forening.
Company purpose
Selskabets formål er produktion, køb og salg
Address
Ved Skoven 35, 1.
Phone
+4520685588
Email
erik@datecmedico.dk
Website
www.datecmedico.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 323 | 553 | 214 | 1.034 | 647 | 1.914 | 1.395 | 5.049 | 4.771 | 5.745 | 2.361 | 1.782 | 1.768 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1.871 | -1.809 | -3.137 | -3.386 | -3.484 | -4.988 |
| EBITDA | 85 | 333 | -20 | 841 | 446 | 1.699 | 1.083 | 3.178 | 2.962 | 2.608 | -1.025 | -1.702 | -3.221 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -20 | -152 | -50 | -50 | -52 | -57 |
| EBIT | 85 | 333 | -20 | 841 | 446 | 1.699 | 1.083 | 3.158 | 2.809 | 2.558 | -1.075 | -1.754 | -3.278 |
| Net financials | 1 | -1 | 0 | 1 | 1 | 1 | -86 | -49 | -83 | 58 | -130 | -876 | -622 |
| Profit before tax | 86 | 332 | -19 | 842 | 447 | 1.700 | 997 | 3.109 | 2.726 | 2.617 | -1.204 | -2.631 | -3.900 |
| Tax | 24 | 88 | -8 | 203 | 108 | 409 | 243 | 688 | 627 | 610 | -260 | -472 | -821 |
| Net profit | 63 | 247 | -11 | 638 | 339 | 1.291 | 754 | 2.422 | 2.099 | 2.007 | -944 | -2.159 | -3.079 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.258 | 1.762 | 1.109 | 1.808 | 2.100 | 3.138 | 4.486 | 6.882 | 3.893 | 3.945 | 2.219 | 11.729 | 31.215 |
| Equity | 906 | 327 | 69 | 707 | 1.046 | 2.337 | 3.091 | 5.513 | 1.199 | 2.515 | 290 | 431 | -2.650 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 120 | 92 | 92 | 98 | 105 | 101 |
| Short-term debt | 284 | 1.385 | 1.010 | 1.086 | 1.047 | 801 | 1.395 | 1.249 | 2.602 | 1.317 | 1.831 | 11.192 | 33.765 |
| Total debt | 284 | 1.385 | 1.010 | 1.086 | 1.047 | 801 | 1.395 | 1.369 | 2.694 | 1.409 | 1.929 | 11.297 | 33.866 |
EBITDA margin
-182.2%
This company
15.8%
Market median
-1253% vs market
20122024
Equity ratio
-8.5%
This company
38.2%
Market median
-122% vs market
20122024
Return on equity
-307914600.0%
This company
18.4%
Market median
-1673449013% vs market
20122024
Net profit margin
-174.1%
This company
8.1%
Market median
-2249% vs market
20122024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20122024
Debt / equity
12.78×
This company
0.62×
Market median
-1961% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ES Management | Management | 2022 | — | — |
HS Founder | Founder | 2010 | — | — |
BB Audit | Audit | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Datec Medico Invest ApS | Company | 100.0% | 100.0% | 2022 |
JOPS Invest ApS | Company | 50.0% | 50.0% | 2020 |
Vejlins Holding ApS | Company | 25.0% | 25.0% | 2020 |
Ottuma Holding ApS | Company | 25.0% | 25.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TELLUS HOLDING ApS
DATEC MEDICO ApS Board members of DATEC MEDICO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Sejersen | Management | 0 companies |
| Henriette Skjødt | Founder | 0 companies |
| Bjarne Bertelsen | Audit | 0 companies |
| Lars Laustsen Gleerup | Chairman | 0 companies |
| Rasmus Bak Skjødt | Board of Directors | 0 companies |
| Ole Preben Skjødt | Chairman | 0 companies |
| Jesper Møller Vejlin | Board of Directors | 0 companies |